A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.

Abstract:

PURPOSE:To determine the dose-limiting toxicities (DLTs) and the maximum-tolerated doses of the paclitaxel, oxaliplatin (LOHP) and capecitabine combination in patients with advanced solid tumors. PATIENTS AND METHODS:Patients received escalating doses of paclitaxel (starting dose 100 mg/m2) and LOHP (starting dose 40 mg/m2) on days 1 and 15 and capecitabine (starting dose 800 mg/m2/day) on days 1-7 and 15-21 every 28 days. DLTs were evaluated in the first cycle. RESULTS:Sixteen patients were treated at four dose-escalating levels. Eleven (68.7%) patients had received two or more prior chemotherapy regimens. The DLT level was reached at paclitaxel 110 mg/m2, LOHP 50 mg/m2 and capecitabine 1,000 mg/m2/day. DLTs due to grade 2-3 neutropenia resulted in treatment delays. No febrile neutropenia or treatment-related death occurred. Grade 2-3 neutropenia occurred in 3 (19%) patients each, grade 2-4 fatigue affected 6 (37.5%) patients, and grade 2-3 neurotoxicity was observed in 2 (12.5%) and 1 (6%) patients, respectively. Two partial responses and four disease stabilizations were achieved. CONCLUSION:The recommended doses for phase II studies are paclitaxel 100 mg/m2 and LOHP 50 mg/m2 on days 1 and 15 and capecitabine 1,000 mg/m2/day on days 1-7 and 15-21 every 4 weeks. This regimen is well tolerated and merits further evaluation.

journal_name

Oncology

journal_title

Oncology

authors

Saridaki Z,Bozionelou V,Kentepozidis N,Kotsakis A,Vardakis N,Kalykaki A,Gioulbasanis I,Karampeazis A,Vamvakas L,Georgoulias V,Mavroudis D

doi

10.1159/000111088

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

45-50

issue

1-2

eissn

0030-2414

issn

1423-0232

pii

000111088

journal_volume

72

pub_type

临床试验,杂志文章

相关文献

ONCOLOGY文献大全
  • Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.

    abstract:BACKGROUND:To date, the clinical characteristics of coronavirus disease 19 (COVID-19)-infected urologic cancer patients are unknown. METHODS:We have analyzed all patients with prostate cancer undergoing hormonal or chemotherapy treatment and receiving telephone and in person pre-triage between March 1 and 27, 2020, at...

    journal_title:Oncology

    pub_type: 新闻

    doi:10.1159/000509434

    authors: Di Lorenzo G,Buonerba L,Ingenito C,Crocetto F,Buonerba C,Libroia A,Sciarra A,Ragone G,Sanseverino R,Iaccarino S,Napodano G,Imbimbo C,Leo E,Kozlakidis Z,De Placido S

    更新日期:2020-01-01 00:00:00

  • Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma.

    abstract::To establish appropriate indications for endoscopic treatment of submucosal invasive gastric carcinoma, we investigated clinicopathologic features and proliferating cell nuclear antigen (PCNA) expression at the deepest invasive portion of 192 differentiated submucosal invasive gastric carcinomas that had been surgical...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227486

    authors: Nishida T,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G

    更新日期:1995-07-01 00:00:00

  • Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.

    abstract::Nucleophosmin/B23 is a nucleolar phosphoprotein which redistributes from nucleoli to nucleoplasm (B23-translocation) when cells are exposed to certain anticancer drugs, particularly intercalators. The B23-translocation assay has been demonstrated in cell culture to correlate with drug effects and to detect drug-resist...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227043

    authors: Finch RA,Chan PK

    更新日期:1992-01-01 00:00:00

  • Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression.

    abstract:INTRODUCTION:Breast cancer is one of the leading causes of death worldwide and is the result of dysregulation of various signaling pathways in mammary epithelial cells. The mortality rate in patients suffering from breast cancer is high because the tumor cells have a prominent invasive capacity towards the surrounding ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000501802

    authors: González-González L,González-Ramírez R,Flores A,Avelino-Cruz JE,Felix R,Monjaraz E

    更新日期:2019-01-01 00:00:00

  • Persistence of chromosomal aberrations in blood lymphocytes of testicular cancer patients. I. The effect of vinblastine, cisplatin and bleomycin adjuvant therapy.

    abstract::Chromosomal aberrations and sister chromatid exchanges were examined in 45 patients with nonseminomatous testicular cancer at different times after the termination of vinblastine, cisplatin and bleomycin (VPB) therapy and in 22 age-matched healthy men and untreated testicular cancer patients. After 36 months, the freq...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226859

    authors: Gundy S,Baki M,Bodrogi I,Czeizel A

    更新日期:1990-01-01 00:00:00

  • A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.

    abstract:PURPOSE:In order to broaden the possibility for anti-MAGE-3 immune targeting, it is important to identify HLA-A24-restricted epitopes derived from MAGE-3, since HLA-A24 is one of the most common alleles in Japanese and Asian people. In the present study, we defined a new MAGE-3 derived, HLA-A24-binding peptide presente...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000091185

    authors: Miyagawa N,Kono K,Mimura K,Omata H,Sugai H,Fujii H

    更新日期:2006-01-01 00:00:00

  • Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.

    abstract:BACKGROUND:It is unclear for whom new anti-human epidermal growth factor receptor 2 (anti-HER2) agents, such as pertuzumab and T-DM1, should be considered. We investigated prognostic factors before neoadjuvant chemotherapy (NAC) among HER2-positive invasive breast cancer patients and those after NAC among patients who ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502910

    authors: Fujita N,Enomoto Y,Inakami K,Yanagisawa T,Iguchi C,Aono T,Nomura T,Yamamoto H,Kasugai T,Shiba E

    更新日期:2020-01-01 00:00:00

  • Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.

    abstract::Glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were determined in 8 patients with disseminated testicular carcinoma before, during and 1 year after termination of a combination chemotherapy with cis-diamminedichloroplatinum (CDDP). The decrease in median GFR in comparison with the pretreatment...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000225718

    authors: Meijer S,Mulder NH,Sleijfer DT,Donker AJ,Sluiter WJ,de Jong PE,Schraffordt Koops H,van der Hem GK

    更新日期:1983-01-01 00:00:00

  • Cancer in humans: exposures and responses in a real world.

    abstract::Cancer causation in humans is at least a three-dimensional problem too often viewed from only two dimensions, especially as far as the two-dimensional results (dose versus response) of cancer induction tests in animals are viewed. The expression of a cancer represents a critical convergence of additional factors in th...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000225113

    authors: Kolbye AC Jr

    更新日期:1976-01-01 00:00:00

  • Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.

    abstract:OBJECTIVES:Primary chemoradiotherapy for locally advanced pancreatic cancer (LAPC) may improve local control, curative resection rate and long-term survival. We performed a phase II study to evaluate toxicity and activity of primary radiation therapy and concurrent chemotherapy with gemcitabine (GEM) twice weekly in pa...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000086993

    authors: Magnino A,Gatti M,Massucco P,Sperti E,Faggiuolo R,Regge D,Capussotti L,Gabriele P,Aglietta M

    更新日期:2005-01-01 00:00:00

  • Inhibition of nitroso chemical carcinogen activation of rat hepatic guanylate cyclase by anticancer agents.

    abstract::Recent studies have demonstrated that nitroso chemical carcinogens activate guanylate cyclase (EC 4.6.1.2) which catalyzes the production of guanosine 3',5'-monophosphate. This nucleotide is thought to be involved in normal and abnormal cell growth. We examined the effect of 3 major classes of anticancer chemotherapeu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225362

    authors: Vesely DL,Levey GS

    更新日期:1979-01-01 00:00:00

  • Sinophobic growth in oestrogen receptor-negative metastatic breast cancer.

    abstract::The mode of growth of tumour cells from primary breast carcinoma in the axillary nodes is shown to be related to the oestrogen receptor (ER) status of the primary tumour. ER-positive primaries are described as tending to show sinophilic growth, the tumour cells spreading along the nodal sinuses; while the ER-negative ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225735

    authors: Hartveit F,Thorsen T,Tangen M,Maehle BO,Thoresen S,Halvorsen JF

    更新日期:1983-01-01 00:00:00

  • Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.

    abstract::Inhibitors of polyamine synthesis were tested for therapeutic effectiveness on transplantable prostate cancer. Inhibition of either ornithine decarboxylase or S-adenosyl-L-methionine decarboxylase (AMDC) by alpha-difluormethylornithine (DFMO) or methylglyoxal-bis[guanylhydrazone] (MGBG), respectively, was associated w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225692

    authors: Dunzendorfer U,Relyea NM,Kleinert E,Balis ME,Whitmore WF Jr

    更新日期:1983-01-01 00:00:00

  • Activities of organ characteristic enzymes and noradrenaline and glycogen contents in the Albert hepatoma of C57BL mice.

    abstract::Further biochemical characterization of the Albert hepatoma has been performed. The following results were obtained: In spite of often repeated transplantations and a medium growth rate, the Albert hepatoma does still contain organ-characteristic enzymes. We have found significant activities of glucokinase, glucose-6-...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225357

    authors: Sydow G

    更新日期:1979-01-01 00:00:00

  • Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trials.

    abstract:OBJECTIVES:This study aimed to evaluate any correlations between baseline creatinine clearance and the development of grade 3/4 toxicities during treatment within oncology phase I trials of molecularly targeted agents where entry criteria mandate a serum creatinine of ≤ 1.5 × the upper limit of normal. METHODS:Documen...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341152

    authors: Basu B,Vitfell-Pedersen J,Moreno Garcia V,Puglisi M,Tjokrowidjaja A,Shah K,Malvankar S,Anghan B,de Bono JS,Kaye SB,Molife LR,Banerji U

    更新日期:2012-01-01 00:00:00

  • Carcinoma of the pancreas in Iraq.

    abstract::This paper presents clinical observations on 130 patients with carcinoma of the pancreas, including 19 with periampullary cancer, the first large study of this disease in Iraq. All of the patients were admitted to the First (one of three) Surgical Unit of the University of Baghdad Teaching Hospital (the Medical City) ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225670

    authors: Al-Bahrani ZR,Al-Mondhiry HA,Al-Saleem T

    更新日期:1982-01-01 00:00:00

  • Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.

    abstract::Breast tumorigenesis is a continuum from preinvasive lesions to early breast cancer and advanced disease. In this article the data supporting the use of the aromatase inhibitor anastrozole in postmenopausal women across this continuum are reviewed. In advanced disease, anastrozole has a significant survival benefit an...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000091180

    authors: Nabholtz JM

    更新日期:2006-01-01 00:00:00

  • New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors.

    abstract::Objective tumor responses and survival rates with standard chemotherapy options for small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) have been disappointing. However, several promising new classes of agents have emerged in recent years, including the taxanes, mitotic spindle inhibitors, antimetabol...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000055387

    authors: Huang CH,Treat J

    更新日期:2001-01-01 00:00:00

  • Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience.

    abstract:BACKGROUND:Since its introduction by Morton in 1992, sentinel lymph node (SLN) biopsy has become a standard procedure in the staging and treatment of primary melanoma and clinically negative regional lymph nodes. The primary aims of this procedure are to ascertain the individual lymphatic drainage patterns of primary t...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000136795

    authors: De Giorgi V,Leporatti G,Massi D,Lo Russo G,Sestini S,Dini M,Lotti T

    更新日期:2007-01-01 00:00:00

  • The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer.

    abstract:AIMS:We investigated the relationship between serum leptin concentrations and polymorphism of the leptin receptor gene and breast cancer. METHODS:Serum leptin concentrations were measured by enzyme-linked immunosorbent assay in 47 women with invasive breast cancer compared with 41 age-matched controls without cancer. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000111097

    authors: Liu CL,Chang YC,Cheng SP,Chern SR,Yang TL,Lee JJ,Guo IC,Chen CP

    更新日期:2007-01-01 00:00:00

  • Potential applications of high-dose megestrol acetate in breast cancer.

    abstract::Empiric clinical trials have revealed new mechanisms by which hormonal therapies may exert their antitumor effects. Initial studies using escalated doses of agents like toremifene and megestrol acetate have yielded interesting results, showing responses in hormone-receptor-negative patients and in patients progressing...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227121

    authors: Abrams JS,Gutheil J,Aisner J

    更新日期:1992-01-01 00:00:00

  • Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.

    abstract::This study sought to examine the relationship between MUC1 expression at the deepest invasive portion, invasive/metastatic potential, and prognosis of colorectal cancer in relation to cellular proliferation. MUC1 expression was detected immunohistochemically using KL-6 antibody (anti-MUC1 monoclonal antibody) in 100 s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011868

    authors: Hiraga Y,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G,Shimamoto F,Kohno N

    更新日期:1998-07-01 00:00:00

  • An update of laparoscopy in cervical cancer staging: is it a useful procedure?

    abstract:OBJECTIVE:It was the aim of this study to report on the role of laparoscopic staging in a large series of locally advanced cervical cancer (LACC) patients and its impact on prognosis. METHODS:Consecutive patients with LACC were considered for surgical staging: gynecological examination, cystoscopy and laparoscopy with...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000351995

    authors: Benedetti Panici P,Perniola G,Tomao F,Fischetti M,Savone D,Di Donato V,Angioli R,Muzii L

    更新日期:2013-01-01 00:00:00

  • Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial.

    abstract:BACKGROUND:The De Gramont regimen (or high-dose LV5FU2, HD-LV5FU2) is considered a standard treatment for metastatic colorectal cancer. The aim of the study was to evaluate the efficacy and the costs of three regimens as compared to HD-LV5FU2: raltitrexed (R), LV5FU2 with a lower dose of folinic acid (LD-LV5FU2), and w...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000100448

    authors: Borget I,Aupérin A,Pignon JP,Abbas M,Bouché O,Mousseau M,Raoul JL,Bedenne L,Cassan P,Clavero-Fabri MC,Stremsdoerfer N,Nasca S,Queuniet AM,Ducreux M,Fédération Francophone de Cancérologie Digestive.

    更新日期:2006-01-01 00:00:00

  • Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.

    abstract:OBJECTIVES:A phase II study was performed to investigate the safety and efficacy of concurrent chemoradiotherapy (CCRT) combined with an orally active fluoropyrimidine, S-1, plus cisplatin for locally advanced esophageal cancer (LAEC). METHODS:CCRT comprised 2 courses, a 30-Gy radiotherapy over 3 weeks plus daily oral...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000348383

    authors: Iwase H,Shimada M,Tsuzuki T,Hirashima N,Okeya M,Hibino Y,Ryuge N,Yokoi M,Kida Y,Kuno T,Tanaka Y,Kato B,Esaki M,Urata N,Kato E

    更新日期:2013-01-01 00:00:00

  • Demonstration and diagnostic significance of pro-gastrin-releasing peptide in medullary thyroid carcinoma.

    abstract::The expression of pro-gastrin-releasing peptide (proGRP) in medullary thyroid carcinoma (MTC) and other histological types of thyroid carcinoma was studied by an immunohistochemical technique, using polyclonal anti-proGRP antiserum. Immunoreactivity for proGRP was detected exclusively in MTC (n = 7); other histologica...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012148

    authors: Inaji H,Komoike Y,Motomura K,Higashiyama M,Ohtsuru M,Funai H,Kasugai T,Koyama H

    更新日期:2000-08-01 00:00:00

  • A phase II study of carboplatin in nasopharyngeal carcinoma.

    abstract::This is a phase II study to evaluate the efficacy and toxicity of short-course carboplatin in advanced-stage nasopharyngeal carcinoma (NPC). Thirty-three previously untreated stage III-IV NPC patients were studied. Carboplatin was given as a rapid intravenous injection every 3 weeks. The dose of carboplatin was calcul...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227689

    authors: Chi KH,Chang YC,Chan WK,Liu JM,Law CK,Lo SS,Shu CH,Yen SH,Whang-Peng J,Chen KY

    更新日期:1997-05-01 00:00:00

  • Elliptinium acetate in metastatic breast cancer--a phase II study.

    abstract::Thirty-five patients with metastatic breast cancer who had received one or two prior chemotherapeutic regimens were treated with elliptinium acetate at a dose of 80 mg/m2 for 3 days every 3 weeks. Of the 33 patients evaluable for response, 1 patient achieved complete remission, 4 achieved partial responses (15% overal...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226797

    authors: Buzdar AU,Hortobagyi GN,Esparza LT,Holmes FA,Ro JS,Fraschini G,Lichtiger B

    更新日期:1990-01-01 00:00:00

  • Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients.

    abstract:OBJECTIVE:The aim of this study was to assess the use of 5-fluorouracil (5-FU), leucovorin and oxaliplatin (FOLFOX) regimens in clinical practice according to their efficacy and toxicity. METHODS:Patients who received oxaliplatin-containing regimens after curative resection for colorectal carcinoma from 10 different o...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1159/000336902

    authors: Uncu D,Aksoy S,Çetin B,Yetişyiğit T,Özdemir N,Berk V,Dane F,Inal A,Harputluoğlu H,Budakoğlu B,Koca D,Sevinç A,Cihan S,Durnalı AG,Özkan M,Öztürk MA,Işıkdoğan A,Büyükberber S,Benekli M,Köş T,Alkış N,Karaca H,Tur

    更新日期:2013-01-01 00:00:00

  • Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion. I. Diagnostic value and use in battery of conventional tumor markers.

    abstract::C-reactive protein (CRP) has been found to be ubiquitous in sera when determined by a highly sensitive methods such as radioimmunoassay. Patients with some tumors appear to have much higher serum levels of CRP than others; in these, CRP seems to reflect the tumor burden. There is a positive correlation with TNM stagin...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225572

    authors: Drahovsky D,Dunzendorfer U,Ziegenhagen G,Drahovsky M,Kellen JA

    更新日期:1981-01-01 00:00:00